Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A number of stocks jumped in the afternoon session after investor sentiment improved on renewed optimism that the US-China ...

LAGOS – In a strategic effort to elevate youth voices in sexual and reproductive health and rights (SRHR), the African Youth and Adolescent Network (AfriYAN) Nigeria, supported by Organon, has ...

In a strategic effort to elevate youth voices in sexual and reproductive health and rights (SRHR), the African Youth and ...

BofA lowered the firm’s price target on Organon (OGN) to $11 from $15 and keeps an Underperform rating on the shares. The firm, in its preview ...

Bank of America Securities analyst Jason Gerberry maintained a Sell rating on Organon (OGN – Research Report) today and set a price target of ...

Attovia Therapeutics has completed an oversubscribed $90 million Series C financing, which the company plans to use along with existing cash and investments to advance its two lead pipeline candidates ...

Ellucian, the leading tertiary education technology solutions provider, today announced a new alliance with KPMG Australia. This alliance will help Australian institutions streamline operations and ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

During Q1 2025, pharmaceutical companies accelerated biosimilar expansion through strategic acquisitions and partnerships in ...

Organon Canada, a global healthcare company with a mission to improve the health of women throughout their lives, today announced that Health Canada has approved NDUVRA (tapinarof cream), 1%, the ...

Organon, a women’s health-focused pharma company based in Jersey City, expects to eliminate 93 jobs as part of an effort to optimize internal operations. In a filing with the state Department of Labor ...